Resistance to arsenic therapy in acute promyelocytic leukemia. [electronic resource]
- The New England journal of medicine May 2014
- 1864-6 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMc1316382 doi
Arsenic Trioxide Arsenicals--therapeutic use Drug Resistance, Neoplasm--genetics Humans Leukemia, Promyelocytic, Acute--drug therapy Mutation Neoplasm Proteins--genetics Oxides--therapeutic use Receptors, Retinoic Acid--genetics Retinoic Acid Receptor alpha